Vasomedical, Inc. - VASO- Profile

Vasomedical, Inc.. The Group's principal activity is to design, manufacture, market and support EECP external counterpulsation system. The system is a microprocessor-based medical device for the non-invasive, outpatient treatment of patients with cardiovascular disease. The device is used in cases of angina, acute myocardial infarction, congestive heart failure (CHF) and carcinogenic shock. It delivers a retrograde arterial pressure wave to the heart, increasing coronary perfusion and reducing ventricular after load. The therapy serves to increase circulation in areas of the heart with less than adequate blood supply and restores systemic vascular function. The products of the Group are sold to treatment providers in the United States through a direct sales force. The Group also provide hospitals, clinics and physician private practices with EECP equipment, treatment guidance and a staff training and equipment maintenance program designed to provide optimal patient outcomes. Medical Equipment Sales accounted for 62% of fiscal 2006 revenues and Medical Equipment Rentals and Services, 38%